| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/06/2004 | WO2004037169A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/06/2004 | WO2004037166A2 Therapeutic guanidines |
| 05/06/2004 | WO2004026822A3 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 05/06/2004 | WO2004009585A3 Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors |
| 05/06/2004 | WO2003106416A3 Chemical process |
| 05/06/2004 | WO2003082853A8 New compounds |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | WO2002020512A9 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 05/06/2004 | US20040087798 Novel amide compounds |
| 05/06/2004 | US20040087796 Substituted carbazoles as inhibitors of spla2 |
| 05/06/2004 | US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 05/06/2004 | US20040087638 Antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders; side effect reduction |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087625 Dietetics; antilipemic agents; anticholesterol agents; reducing triglycerides |
| 05/06/2004 | US20040087623 Pyrazole derivatives against tgf overexpression |
| 05/06/2004 | US20040087601 Pyrimidine derivatives as IL-8 receptor antagonists |
| 05/06/2004 | US20040087599 cGMP-PDE inhibitors for the treatment of erectile dysfunction |
| 05/06/2004 | US20040087595 1-aryl- or 1-alkylsulfony-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands |
| 05/06/2004 | US20040087592 Treatment of malaria with farnesyl protein transferase inhibitors |
| 05/06/2004 | US20040087591 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 05/06/2004 | US20040087588 Parp inhibitors |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087570 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 05/06/2004 | US20040087568 Substituted anthranilic amide derivatives and methods of use |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040087548 Anticancer agents and treating immune disorders |
| 05/06/2004 | US20040087547 Orally administered antitumor agents |
| 05/06/2004 | US20040086745 Emits bluish light with a high purity of color |
| 05/06/2004 | US20040083558 Oxidation hair color dyes, with properties as bright, chromatic, weatherproofing, wash and wear, chemical resistance |
| 05/06/2004 | EP1415990A1 Diazepan derivatives useful as factor X inhibitor |
| 05/06/2004 | EP1415989A1 Synthesis of 3-acylaminopyrazoles |
| 05/06/2004 | EP1415986A1 Spiro compounds |
| 05/06/2004 | EP1414817A1 Substituted isoindoles and e use thereof |
| 05/06/2004 | EP1414816A1 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
| 05/06/2004 | EP1414815A1 Tetrahydropyridazine derivatives and their use as pesticides |
| 05/06/2004 | EP1414805A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1325011B1 Methods and compounds for treating proliferative diseases |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP0817776B1 Formaldehyde-free 1,3,5-triazine based crosslinkers |
| 05/06/2004 | CA2503471A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 05/06/2004 | CA2502932A1 Triazole compounds for the treatment of dysmenorrhoea |
| 05/06/2004 | CA2502914A1 2-pyrrolidones as ep4 receptor agonists |
| 05/06/2004 | CA2502478A1 1-phenylpyrrolidine-2-one-3-carboxamides |
| 05/06/2004 | CA2501231A1 2-alkyl-(2-amino-3-aryl-propionyl)-piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 05/06/2004 | CA2500848A1 Mitotic kinesin inhibitors |
| 05/06/2004 | CA2498215A1 Oxindole substituted piperazine derivatives |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1148368C Preparation of asymmetric cyanine dyes for DVD-R CD |
| 05/05/2004 | CN1148357C Triazole derivative |
| 05/05/2004 | CN1148355C Pyridazin-3-one derivatives and medicines containing the same |
| 05/05/2004 | CN1148190C Immunodulatory drug composition |
| 05/04/2004 | US6730792 β3 adrenergic agonists |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 05/04/2004 | US6730689 Heterocyclic amides such as n-(4-(2-(((methyl)amino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-1-(3-amino-1,2-benzisoxazol-5-yl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide, used as anticoagulants; prophylaxis of cardiovascular disorders |
| 05/04/2004 | US6730683 Such as 1-cyclohexyl-4-(4-fluorophenyl)-5-((2-phenylamino)pyrimidin-4-yl)imidazole; for use as cytokine inhibitors |
| 04/29/2004 | WO2004035571A1 Substituted indoles and their use as hcv inhibitors |
| 04/29/2004 | WO2004035569A2 Novel compounds with antibacterial activity |
| 04/29/2004 | WO2004035567A1 High purity ondansetron hydrochloride dihydrate and process for its synthesis |
| 04/29/2004 | WO2004035550A1 Novel bicyclic inhibitors of hormone sensitive lipase |
| 04/29/2004 | WO2004035549A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 04/29/2004 | WO2004035548A1 Novel compounds |
| 04/29/2004 | WO2004035545A2 Azolecarboxamide herbicides |
| 04/29/2004 | WO2004035544A1 Benzo[d]azepine derivatives for the treatment of neurological and psychiatric disorders |
| 04/29/2004 | WO2004035049A1 Process for preparing losartan potassium with improved flowability |
| 04/29/2004 | WO2004034972A2 Compounds, compositions, and methods |
| 04/29/2004 | WO2004022712A3 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE |
| 04/29/2004 | WO2004016086A3 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 04/29/2004 | WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/29/2004 | WO2004004730A3 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders |
| 04/29/2004 | WO2003104255A3 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives as ligands for the neuropeptide y5 receptor |
| 04/29/2004 | WO2003097649A3 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/29/2004 | WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082786 Piperazine based inhibitors of factor xa |
| 04/29/2004 | US20040082785 Process for making an aldehyde |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/29/2004 | US20040082759 Process for preparing distamycin derivatives |
| 04/29/2004 | US20040082663 Imidazoline receptor binding compounds |
| 04/29/2004 | US20040082645 Drug for detaching tumor |
| 04/29/2004 | US20040082639 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 04/29/2004 | US20040082637 Heterocyclic topoisomerase poisons |
| 04/29/2004 | US20040082636 Method for the prophylaxis or treatment of glomerulonephritis |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 04/29/2004 | US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
| 04/29/2004 | US20040082590 Dietetics; antidiabetic agents; sexual disorders |
| 04/29/2004 | US20040082586 Insecticides, nematocides |
| 04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |
| 04/29/2004 | US20040082583 Chemical compounds |
| 04/29/2004 | US20040082582 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/29/2004 | US20040082581 Controlling cell proliferation; antitumor agents |